3Authors/Task Force Members, Camm AJ, Lip GY, et al. 2012 focused update of the ESC Guidlines for the management of atrial fibrillation An update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association[J]. Europace, 2012, 14(10): 1385-1413.
4Hu D, Sun Y. Epidemiology, risk factors for stroke, and manage- ment of atrial fibrillation in China [ J ]. J Am Coil Cardiol, 2008, 52:865-868.
5Hirsh J, Fuster V, Ansell J, et al. American Heart Association/ American College of Cardiology Foundation guide to warfarin thera- py[ J]. J Am Coil Cardio1,2003,41 : 1633-1652. [ No authors listed].
6Stroke Prevention in Atrial Fibrillation Study. Final Results[ J]. Circulation, 1991,84:527-539.
8Diker E, Aydogdu S, Ozdemir M, et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heatrt disease [ J ]. Am J Cardiol, 1996,77:96-98.
9Nguyen TN, Hilmer SN, Cumming RG. Review of epidemiology and management of atrial fibrillation in developing countries [ J ]. Int J Cardio1,2013 ,167 :2412-2420.
10Levy S, Maarek M, Coumel P, et al. Characterization of different subsets of atrial fibrillation in general practice in France : The AL- FA study. The College of French Cardilolgists [ J ]. Circulation, 1999,99 : 3028 -3035.
